The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hornell, T. M. C.
Right arrow Articles by Mellins, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hornell, T. M. C.
Right arrow Articles by Mellins, E. D.
The Journal of Immunology, 2006, 176: 3536-3547.
Copyright © 2006 by The American Association of Immunologists

Human Dendritic Cell Expression of HLA-DO Is Subset Specific and Regulated by Maturation1

Tara M. C. Hornell*, Timo Burster*, Frode L. Jahnsen{dagger}, Achal Pashine2,*, Maria T. Ochoa{ddagger}, James J. Harding*, Claudia Macaubas*, Andrew W. Lee*, Robert L. Modlin{ddagger} and Elizabeth D. Mellins3,*

* Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305; {dagger} Laboratory for Immunochemistry and Immunopathology, Rikshospitalet University Hospital, Oslo, Norway; and {ddagger} Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095

Expression of HLA-DO (DO) in cells that express HLA-DM (DM) results in an altered repertoire of MHC class II/peptide complexes, indicating that DO modulates DM function. Human and murine B cells and thymic epithelial cells express DO, while monocytes/macrophages do not. Monocyte-derived dendritic cells (DC) also have been found to be DO-negative, leading to the assumption that DC do not express DO. In this study, we report that, in fact, certain types of human primary DC express DO. These include Langerhans cells (LC) and some subtypes of circulating blood DC. Specifically, the majority of BDCA-3+ DC, a small subset of uncertain function, are DO+, while smaller proportions of CD11c+, BDCA-1+ (myeloid) DC, at most a minority of CD123+/BDCA-2+ (plasmacytoid) DC, and no detectable CD16+ (myeloid) DC, express DO. Immunohistochemistry of human tonsil sections demonstrates that tonsillar interdigitating DC are also DO+. In a subset of immature LC with higher DO expression, an increased fraction of surface DR molecules carry CLIP peptides, indicating that DO functions as a DM inhibitor in these cells. LC expression of DO is down-regulated by maturation stimuli. DM levels also decrease under these conditions, but the DM:DO ratio generally increases. In the myeloid cell types tested, DO expression correlates with levels of DObeta, but not DO{alpha}, implying that modulation of DObeta regulates DO dimer abundance in these cells. The range of APC types shown to express DO suggests a broader role for DO in immune function than previously appreciated.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. H. Rinderknecht, M. P. Belmares, T. L. W. Catanzarite, A. J. Bankovich, T. H. Holmes, K. C. Garcia, N. K. Nanda, R. Busch, S. Kovats, and E. D. Mellins
Posttranslational Regulation of I-Ed by Affinity for CLIP
J. Immunol., November 1, 2007; 179(9): 5907 - 5915.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Fallas, W. Yi, N. A. Draghi, H. M. O'Rourke, and L. K. Denzin
Expression Patterns of H2-O in Mouse B Cells and Dendritic Cells Correlate with Cell Function
J. Immunol., February 1, 2007; 178(3): 1488 - 1497.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.